帕金森病中的金属纳米材料:早期检测和向治疗的变革性方法
Amira Mansour1, Mariam Hossam Eldin1, Ibrahim M El-Sherbiny1
1Nanomedicine Laboratories, Center for Materials Science, Zewail City of Science and Technology, 6th October City, 12578 Giza, Egypt. ielsherbiny@zewailcity.edu.eg.
Journal of materials chemistry. B
|March 3, 2025
概括
基于金属的纳米材料 (MNMs) 显示出对早期帕金森病 (PD) 检测和治疗的希望,克服了当前方法的局限性. 这种纳米技术提供了改善的药物输送和神经保护,用于管理PD进展.
科学领域:
- 神经科学是一个神经科学.
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,患病率越来越高,影响全球数百万人.
- 目前PD的诊断工具和治疗方法缺乏早期干预和疾病修改的敏感性,特异性和有效性.
- 传统的PD疗法提供症状缓解,长期益处有限,潜在副作用有限.
研究的目的:
- 审查使用金属基纳米材料 (MNMs) 检测和治疗帕金森病的进展.
- 突出现有的PD诊断和治疗方法的局限性.
- 探索纳米技术的潜力,以解决PD管理中的挑战.
主要方法:
- 关于金属基纳米材料 (MNMs) 在帕金森病研究中的当前文献的综述.
- 分析MNM的物理化学特性,用于PD中的向细胞和分子相互作用.
- 对MNM进行的临床前研究进行审查,以诊断PD,药物输送和神经保护.
主要成果:
- 在PD中,MNM提供了独特的特性,用于增强药物输送,改进成像和生物传感.
- 黄金和银纳米颗粒显示出穿越血脑屏障的潜力,用于早期诊断和向治疗.
- 基于纳米技术的方法在克服传统PD治疗的局限性方面表现有前途.
结论:
- 基于金属的纳米材料代表了一种变革性的方法,可以彻底改变帕金森病的检测和治疗.
- 对MNMs的疗效和潜在毒性的进一步研究对于临床转化至关重要.
- 纳米技术具有显著的潜力,可以改善PD患者的治疗结果和生活质量.
相关概念视频
Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


